Patent Assignment
Reel/Frame 032678/0639
Release of Security Interest
Recorded: 2014-04-15
Pages: 3
Assignor
FULCRUM CAPITAL PARTNERS, INC.
Executed: 2014-04-15
Assignee
CONCORDIA PHARMACEUTICALS, INC.
CHANCERY HOUSE, HIGH STREET, BRIDGETOWN, BARBADOS
Covered Properties
(4)
Extended Release Clonidine Formulation
Patent:
5,484,607 →
Application:
08/136,309 →
Pleasant-Tasting Aqueous Liquid Composition of a Bitter-Tasting Drug
Patent:
5,763,449 →
Application:
08/692,081 →
Extended Release Clonidine Formulation (Tablet)
Patent:
5,869,100 →
Application:
08/881,314 →
Extended Release Clonidine Formulation (Capsule)
Patent:
6,030,642 →
Application:
08/884,283 →
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Apr 15, 2014
From: BG CAPITAL GROUP LIMITED; UNIVERSAL CASUALTY COMPANY
To: CONCORDIA PHARMACEUTICALS, INC.
Reel/Frame 032678/0705 →
Release of Security Interest
Apr 21, 2015
From: GE CAPITAL CANADA FINANCE INC.
To: CONCORDIA HEALTHCARE USA INC.; CONCORDIA HEALTHCARE CORP.; CONCORDIA HEALTHCARE INC.; CONCORDIA LABORATORIES INC.
Reel/Frame 035460/0702 →
Security Interest
Apr 21, 2015
From: CONCORDIA HEALTHCARE CORP.; CONCORDIA PHARMACEUTICALS, INC.; CONCORDIA LABORATORIES INC.; PINNACLE BIOLOGICS, INC.
To: ROYAL BANK OF CANADA
Reel/Frame 035456/0015 →
Security Agreement
Oct 22, 2015
From: CONCORDIA PHARMACEUTICALS INC.; CONCORDIA LABORATORIES INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 036926/0751 →
Release of Security Interest
Nov 5, 2015
From: ROYAL BANK OF CANADA
To: CONCORDIA HEALTHCARE USA INC.; CONCORDIA HEALTHCARE CORP.; CONCORDIA HEALTHCARE INC.; CONCORDIA LABORATORIES INC.
Reel/Frame 036973/0890 →
Security Interest
Oct 14, 2016
From: CONCORDIA LABORATORIES INC.; CONCORDIA PHARMACEUTICALS INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 040022/0034 →
Termination and Release of Security Interest in Intellectual Property Recorded at Reel/Frame 036926/0751
Sep 7, 2018
From: GOLDMAN SACHS BANK USA
To: CONCORDIA LABORATORIES INC.; CONCORDIA PHARMACEUTICALS INC.
Reel/Frame 047030/0156 →
Termination and Release of Security Interest in Intellectual Property Recorded at Reel/Frame 040022/0034
Sep 7, 2018
From: U.S. BANK NATIONAL ASSOCIATION
To: CONCORDIA LABORATORIES INC.; CONCORDIA PHARMACEUTICALS INC.
Reel/Frame 047030/0171 →
Corrective Assignment to Correct the Statement of Document Serving as an Oath of Declaration Previously Recorded at Reel: 047030 Frame: 0157. Assignor(S) Hereby Confirms the Termination and Release of Security Interest in Intellectual Property.
Oct 30, 2018
From: GOLDMAN SACHS BANK USA
To: CONCORDIA LABORATORIES INC.; CONCORDIA PHARMACEUTICALS INC.
Reel/Frame 047365/0010 →
Corrective Assignment to Correct the Incorrect Statement That This Document Serves as an Oath/Declaration Previously Recorded on Reel 047030 Frame 0172. Assignor(S) Hereby Confirms the Termination and Release of Security Interest in Intellectual Property Recorded at Reel/Frame 040022/0034.
Oct 30, 2018
From: U.S. BANK NATIONAL ASSOCIATION
To: CONCORDIA LABORATORIES INC.; CONCORDIA PHARMACEUTICALS INC.
Reel/Frame 047364/0962 →